Press Release: MMJ highlight their litigation with DEA Re Cannabis-Derived Therapeutics for Huntington’s Disease

It sounds like they are so pissed off they have gone public but also it’s just another one of the endless pointers that doesn’t bode well for re-sheduling is it actually even gets on the table again   Key FDA Marijuana Response, MMJ International Holdings Advances Cannabis-Derived Therapeutics for Huntington’s Disease Monday, 10 February 2025 […]

Leave a Reply

Your email address will not be published. Required fields are marked *